课题基金 / 基金详情

REGULATION OF VIRUS INDUCED PROGRAMMED CELL DEATH

REGULATION OF VIRUS INDUCED PROGRAMMED CELL DEATH
病毒诱导的程序性细胞死亡的调节
批准号:
2856049
负责人:
PAUL D FRIESEN
金额:
$19.21万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-01 至 2001-12-31

项目摘要

项目成果

PAUL D FRIESEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Programmed cell death or apoptosis is a built-in, signal-induced process by which a cell self-destructs. It is a mechanism that provides control of cell numbers, and is therefore critical for normal development and tissue homeostasis. In humans, aberrant programmed cell death is associated with tumorigenesis, neurodegenerative diseases, immunodeficiency, and viral pathogenesis. Although the apoptotic pathway is highly conserved between diverse organisms and involves central death regulators, the cellular mechanisms involved in execution and regulation of apoptosis are largely unknown. Animal viruses that induce apoptosis can block cell death by the expression of novel apoptotic suppressors. The mechanisms for viral intervention of host apoptosis have therefore provided key insight into the cell death program. It is the long term objective of this proposal to define the molecular mechanisms by which apoptosis is regulated through the study of the baculovirus-encoded apoptotic regulators, p35 and iap. Our approach focuses on the use of baculovirus-infected insect cells as a powerful, yet convenient system for molecular analysis of the induction and suppression of apoptosis. In an integrated set of experiments that build on recent advances in programmed cell death, we use biochemical, genetic, and cell biology approaches to determine the molecular mechanism of P35 and vIAP anti- apoptotic activity. An extensive collection of loss-of-function p35 mutations will be used to characterize the molecular interaction between P35 and the CED-3/ICE-related death proteases, for which P35 is a potent inhibitor. By focusing on the invertebrate CED-3/ICE-like protease(s) induced by baculovirus infection, we also investigate the mechanisms involved in activation and inhibition of these critical cell death enzymes. In genetic studies, we use novel p35- and iap-expressing baculovirus recombinants, as well as stably transfected insect cell lines, to definitively place the anti-apoptotic activity of P35 and vIAP into the conserved death pathway. Lastly, we use p35 and iap as tools to define the mechanisms by which large DNA viruses trigger apoptosis in their host cell and contribute to pathogenesis. Collectively, these studies are expected to yield important insight into the mechanisms by which programmed cell death is regulated and thereby facilitate the long term design of novel therapeutic strategies for treatment of apoptosis- linked human disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF VIRUS-INDUCED PROGRAMMED CELL DEATH
  • 批准号:
    7061620
  • 项目类别:
  • 资助金额:
    $24.6万
  • 财政年份:
    1997
  • 负责人:
    PAUL D FRIESEN
  • 依托单位:
REGULATION OF VIRUS INDUCED PROGRAMMED CELL DEATH
  • 批准号:
    6341661
  • 项目类别:
  • 资助金额:
    $20.37万
  • 财政年份:
    1997
  • 负责人:
    PAUL D FRIESEN
  • 依托单位:
REGULATION OF VIRUS-INDUCED PROGRAMMED CELL DEATH
  • 批准号:
    6835707
  • 项目类别:
  • 资助金额:
    $25.2万
  • 财政年份:
    1997
  • 负责人:
    PAUL D FRIESEN
  • 依托单位:
REGULATION OF VIRUS INDUCED PROGRAMMED CELL DEATH
  • 批准号:
    2005060
  • 项目类别:
  • 资助金额:
    $18.11万
  • 财政年份:
    1997
  • 负责人:
    PAUL D FRIESEN
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: